Seeking Alpha

R.J Steffens » Articles |

Sort by:
Latest | Editors' Picks | Most Commented | Most Popular
Articles by Ticker

Latest Comments on R.J Steffens' Articles

  1. nougatine1 on A N.I.C.E. Development for Generex Oral-lyn in the U.K.: Never forget...Medical Director is one of the 3 AMGEN's... more »
  2. guitarz on Generex Biotech's Oral-lyn Granted Special Access Authorization by Health Canada: I would like razormd comments to be answered by a GNBT... more »
  3. Jolly_Rancher on Four Drug Companies Vying for Diabetes Patients: GNBT is not a genuine company. Did you listen to the latest... more »
  4. R.J Steffens on Genentech and Generex: New HER2/neu Research: "The small life science company is a fully owned subsidiary of... more »
  5. raytayzmd on Genentech and Generex: New HER2/neu Research: ...back again, huh?...what is this -- about your tenth post... more »
  6. R.J Steffens on Four Drug Companies Vying for Diabetes Patients: Hi GreenClay, Generex has conducted dose-response studies on... more »
  7. GreenClay on Four Drug Companies Vying for Diabetes Patients: As a major biotech investor and as a diabetic who has been on... more »
  8. NOWHEREMAN on Four Drug Companies Vying for Diabetes Patients: DMYDY, Pink sheets, advanced stage potential Type 1 cure, highly... more »
  9. taoprod on Four Drug Companies Vying for Diabetes Patients: Gnbt:: a possible buy out candidate. more »
  10. User 219789 on Four Drug Companies Vying for Diabetes Patients: RJS is full of bull. I beleived him once, not anymore. more »
  11. Dipsite on ADA's 68th Scientific Sessions: A New Look at Insulin Therapy: GNBT is up for acquistion. Most of the big players scratched their... more »
  12. R.J Steffens on ADA's 68th Scientific Sessions: A New Look at Insulin Therapy: "the downtrend was not accompanied by any vlome to speak of, and... more »
  13. R.J Steffens on ADA's 68th Scientific Sessions: A New Look at Insulin Therapy: I think part of the problem has to do with the overall state of... more »
  14. hatshepsut1988 on ADA's 68th Scientific Sessions: A New Look at Insulin Therapy: If GNBT is as promising as described then why is the stock dying... more »
  15. Thanh Nguyen on Generex Biotechnology: Oral-lyn Buccal Insulin Takes Center Stage: Anyone known why The pharmarcist & Family Doctor don't event know... more »